ZA711821B - Pharmaceutical compositions and methods of treatment - Google Patents

Pharmaceutical compositions and methods of treatment

Info

Publication number
ZA711821B
ZA711821B ZA711821A ZA711821A ZA711821B ZA 711821 B ZA711821 B ZA 711821B ZA 711821 A ZA711821 A ZA 711821A ZA 711821 A ZA711821 A ZA 711821A ZA 711821 B ZA711821 B ZA 711821B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA711821A
Inventor
M Sandler
Original Assignee
M Sandler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Sandler filed Critical M Sandler
Publication of ZA711821B publication Critical patent/ZA711821B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA711821A 1970-03-24 1971-03-22 Pharmaceutical compositions and methods of treatment ZA711821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1436570 1970-03-24

Publications (1)

Publication Number Publication Date
ZA711821B true ZA711821B (en) 1971-12-29

Family

ID=10039897

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA711821A ZA711821B (en) 1970-03-24 1971-03-22 Pharmaceutical compositions and methods of treatment

Country Status (2)

Country Link
GB (1) GB1297411A (en)
ZA (1) ZA711821B (en)

Also Published As

Publication number Publication date
GB1297411A (en) 1972-11-22

Similar Documents

Publication Publication Date Title
AU2489471A (en) Treatment of particles
IL37098A0 (en) Skin treatment composition and its preparation
AU2489371A (en) Treatment of particles
PH9765A (en) Aminophenylamidines and cycloamidines,compositions containing them and method of use
ZA717486B (en) Treatment of teeth
GB1365661A (en) Prparation of medicinal and food compositions
CA934469A (en) Apparatus of medical and other types
ZA713249B (en) Therapeutic process and compositions
HK15678A (en) Preparation of 5-fluoropyrimidines and novel intermediate therefrom
ZA713073B (en) Anthelmintic composition and method of use
IL37830A (en) Derivatives of 1-phenoxy-2-hydroxy-3-amino-propane,their preparation and pharmaceutical compositions containing them
AU458749B2 (en) Process for the treatment and care of dentures
MY7700129A (en) Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia
IL37956A0 (en) Substituted malonamides and pharmaceutical compositions containing them
AU464700B2 (en) Composition and method of treatment
AU462834B2 (en) Pharmaceutical composition and method of treatment
HK79079A (en) Complexes of alpha-6-deoxy-5-hydroxytetracycline and their preparation
IE34921B1 (en) Pharmaceutical and dietetic composition
AU3224471A (en) Treatment of filtrate and gas
IL37276A0 (en) Antiviral compositions and methods of use
ZA711821B (en) Pharmaceutical compositions and methods of treatment
ZA711552B (en) Treatment of coal extracts
IL37236A0 (en) New cardenolides and bufadienols pharmaceutical compositions them
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
ZA708706B (en) Antheilmintic composition and method of use